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Running head 
Telerehabilitation in COPD supports long-term exercise maintenance. 
 
Abstract 
Introduction. Pulmonary rehabilitation (PR) is an integral part of the management of 
Chronic Obstructive Pulmonary Disease (COPD). However, many patients do not 
access or complete PR, and long-term exercise maintenance has been difficult to 
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achieve after PR. This study aimed to investigate feasibility, long-term exercise 
maintenance, clinical effects, quality of life and use of hospital resources of a 
telerehabilitation intervention. 
Methods. Ten patients with COPD were offered a 2-year follow-up via 
telerehabilitation after attending PR. The intervention consisted in home exercise, 
telemonitoring and self-management via a webpage combined with weekly 
videoconferencing sessions. Equipment included a treadmill, a pulse oximeter and a 
tablet. Data collected at baseline, 1 year and 2 years were 6-minute walking distance 
(6MWD), COPD Assessment Test (CAT), EQ-5D, hospitalisations and outpatient visits. 
Results. No dropout occurred. Physical performance, lung capacity, health status, and 
quality of life were all maintained at 2 years. At 1 year, 6MWD improved by a mean of 
40 meters from baseline, CAT decreased by 4 points, and EQ VAS improved by 15.7 
points. 
Discussion. Long-term exercise maintenance in COPD via telerehabilitation is feasible. 
Results are encouraging and suggest that telerehabilitation can prevent deterioration, 





Pulmonary rehabilitation (PR) is an evidence-based component of the disease 
management of chronic obstructive pulmonary disease (COPD) [1-3]. The main goal of 
PR is to improve the patient’s conditions, both physically and psychologically, and to 
promote long-term adherence of health-enhancing behaviours [4]. PR improves 
dyspnoea, physical performance and quality of life in COPD [4]. However, benefits 
diminish over the succeeding 12 months without any maintenance strategy [5], and 
long-term exercise maintenance has been difficult to achieve after short-term treatment 
[6]. Supervised post-rehabilitation exercise programs appear to be effective in 
preserving exercise capacity in the medium term [7]. Nevertheless, the optimal 
maintenance intervention to sustain benefits of PR over the long term remains still 
unknown [5,6,8]. Regular exercise for patients with COPD is difficult for many reasons, 
including variation in day to-day condition, exacerbations, hospital admissions, 
transportation problems, lack of support and follow-up programs [9]. Developing new 
ways to maintain regular exercise, thus extending the effects of PR, is an important goal 
in COPD management. 
Telemedicine has the potential to support disease management of COPD. 
Telerehabilitation refers to the use of information and communication technologies to 
provide rehabilitation services to people remotely in their homes or other environments 
[10]. The primary aim is to provide equitable access to rehabilitation [11]. This is 
especially important to people living in rural areas. In contrast to traditional centre-
based PR programs, undertaking PR within the home environment may promote more 
effective integration of exercise routines into daily life over the longer term [12].  
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Evidence of the use of telemedicine in PR is still scarce [4]. A recent review 
showed that telemedicine may lead to increased physical activity level in patients with 
COPD, but no effect was found on exercise capacity or dyspnoea [13]. Other studies 
showed promising results for telerehabilitation in COPD in regards to feasibility, safety, 
exercise capacity, physical activity and health-related quality of life [14-19]. However, 
all interventions had a short-term duration. So far, no telerehabilitation intervention was 
conducted to support exercise maintenance and long-term effects. 
We conducted a pilot study where a long-term telerehabilitation intervention for 
patients with COPD was offered over a 2-year period. The aim was to investigate 





A 2-year pilot study was conducted to test long-term exercise maintenance in COPD via 
telerehabilitation. The study was conducted by the Norwegian Centre for Integrated 
Care and Telemedicine (NST), University Hospital of North Norway (UNN) and the 
rehabilitation centre LHL-klinikkene Skibotn. Participants were 10 patients with 
moderate to severe COPD recruited after attending a 4-week inpatient PR. Their clinical 
status was therefore stable and their physical conditions optimised. Inclusion and 
exclusion criteria are described in detail in Table 1. The study was approved by the 




The primary objective was to determine whether long-term telerehabilitation in COPD 
was feasible and could promote exercise maintenance and self-management. Feasibility 
was assessed in terms of completion rate, measured as the number of completers 
divided by the number of participants. Completers were defined as those participants 
actively undertaking the study procedures until the end of the intervention, while 
dropouts where those who abandoned before [21]. Frequency of training sessions was 
calculated to measure how active patients were in maintaining exercise. Frequency of 
registrations of daily symptoms were used to assess maintenance of self-management 
routines. Other study objectives included impact on patients’ physical performance, 
lung capacity, body weight status, health status, quality of life, and subjective 
impression of change (Table 2). All data were collected at baseline, 1 year and 2 years. 
The study also tested whether long-term telerehabilitation was associated with a change 
in healthcare resources utilisation. Data on hospitalisations and outpatient visits were 
collected from the Norwegian Patient Registry for the 2 years of follow-up and for the 2 
years prior to enrolment. 
The telerehabilitation intervention 
Telerehabilitation was designed as a comprehensive intervention consisting in home 
exercise, telemonitoring and self-management. The service was offered as 2-year 
follow-up to patients with COPD. The 2-year duration was proposed since there have 
been almost no previous reports of studies lasting longer than 12 months. After 
attending a PR program, participants were supplied with equipment for home exercise 
and videoconferencing so that they could be supervised by a physiotherapist. Equipment 
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for home exercise consisted of a treadmill installed in the patients’ homes. Folding 
treadmills were chosen since they are ideal for in-home use, where space is a concern, 
and are less expensive. Treadmills supported speed up to 16 km/h and incline up to 
10%. A pulse oximeter (Nonin GO2 LED) was provided to monitor oxygen saturation 
at rest and while exercising. A tablet computer (Apple iPad 2) was used to perform 
weekly videoconferencing sessions with a physiotherapist and to access a web-based 
self-management platform. A tablet holder mounted on the treadmill allowed using 
safely the tablet while exercising (Figure 1). A mobile application for 
videoconferencing (LifeSize, ClearSea) could connect the participant’s tablet to H.323 
and SIP standards-based systems, desktop computers or mobile clients. Communication 
was performed with AES encryption. Videoconferencing was initiated from a 
rehabilitation centre and performed through the application running on the participant’s 
tablet (Figure 2). Participants used the web-based platform to access an individual 
training programme, to fill in a daily diary and a training diary, and to access historical 
data. The information was also accessible to the physiotherapist and used for discussion 
with the patients. 
Statistical analyses 
Data from baseline (post PR), 1-year, and 2-year visits for all subjects were evaluated 
with descriptive statistics and analysis of variance (ANOVA) with repeated measures. 
Continuous variables are reported as mean ± standard deviation [min-max]. Categorical 
variables are reported as counts and percentages. Normality of distribution was tested 
by means of the Shapiro-Wilk test. Effects of the long-term telerehabilitation were 
evaluated with an ANOVA with repeated measures. A value of ︎P<0.05 was considered 
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significant. Bonferroni post hoc test was used to discover which specific means differed 
in case the overall ANOVA result was significant. All statistical analyses were 
performed with IBM SPSS Statistics Version 22. 
Study procedures 
Participants were enrolled by a lung specialist and a trained physiotherapist during a 
baseline visit at the rehabilitation centre. A clinical assessment included conduction of 
spirometry and 6-minute walking test, measurement of bodyweight and height, and 
collection of the study questionnaires. After enrolment, the equipment was installed at 
the participant’s home. A training session on the use of the equipment was performed. 
A test videoconferencing session between the participant and the physiotherapist at the 
rehabilitation centre was also conducted. 
During the study participants were asked to fill in a daily electronic form for 
self-management of symptoms including: oxygen saturation (at rest); and the 
Breathlessness, Cough and Sputum Scale (BCSS) [22]. Each participant received an 
individual exercise program consisting of interval training on the treadmill, 
recommended three times a week. This was accessible from the web-based platform. 
Participants were also encouraged to perform strength training exercises consisting 
mainly of squats and calf raise (3 sets of 10 reps) and to do any physical activity on 
their own. Interval training consisted of 10-min warm-up, followed by three or four 3-4-
min exercise bouts with a perceived exertion of 5-6 on the Borg CR10 scale [23], 
interposed by 2-3-min active recovery periods with a perceived exertion of 3-4. The 
training session ended with a 5-min cool-down. This gave a total exercise time ≥ 30 min 
[4]. The number and length of intervals were adjusted to the participant’s condition. 
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Speed and/or incline of the treadmill were adjusted individually during the study to 
reach the desired perceived exertion. After each training session, participants were 
asked to fill in an electronic form including: programme completion (duration); 
perceived exertion; oxygen saturation (lowest value during exercise); and heart rate 
(highest value during exercise). 
Participants had weekly individual videoconferencing sessions with the 
physiotherapist, who was able to supervise them remotely while exercising. The 
physiotherapist supported and educated the patients in health-enhancing behaviour, 
focusing on increasing their motivation for exercise training and other physical 
activities. Self-efficacy strategies were emphasized so that the patients could gain 
insight in their own health and skills to optimally manage their illness and everyday life. 
Participants had follow-up visits at the rehabilitation centre after 1 year and 2 
years. During these visits spirometry, 6MWD, bodyweight and height were measured 
and the same baseline questionnaires were collected. At study exit, the Patient Global 
Impression of Change (PGIC) questionnaire was also collected [24]. During the study, 
participants received standard care, with their General Practitioner as main contact, and 
attended the hospital for specialised care when needed. 
 
Results 
Study timelines and population  
Ten participants were enrolled from January 2012 to May 2012. The baseline 
characteristics of the participants are shown in Table 3. Follow-up visits were held in 
June 2013 and May 2014. 
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Feasibility and exercise maintenance 
On average, patients participated in the study for 740±26 days. All patients attended the 
baseline, 1-year and 2-year visits and data were collected at all time points. No dropout 
occurred during the study. The completion rate was therefore 100%. Patients 
experienced voluntarily and non-voluntarily relapses due to holidays, traveling, sickness 
or hospital admissions. However, all patients rejoined the program after each break. On 
average, patients registered 1.7 training sessions/week via the webpage during the 2-
year intervention period. Frequency decreased from the first to the second year, but all 
the patients maintained exercise until the end of the study. Patients registered on 
average 3.0 daily measurements/week, thus maintaining also their self-management 
routines. 
Clinical status 
After 1 year, 6MWD improved by a mean of 40 meters compared to baseline (post-PR) 
(Table 4). This exceeded the minimal important difference (MID) in COPD, 
corresponding to 30 meters [25]. After 2 years, 6MWD decreased to a value in line with 
baseline, but still higher then the pre-PR measurement (464±108). Mean FEV1 (% of 
pred.) increased after 1 year, while it declined during the second year. BMI showed a 
slight reduction over the 2 years. Mostly, patients who were overweight reduced their 
weight reaching a BMI closer to 25. A repeated measures ANOVA did not show any 
statistically significant difference between time points. Long-term telerehabilitation 
succeeded in maintaining clinical effects over a 2-year period. 
Health status and quality of life 
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After 1 year, the total score for the CAT decreased by a mean of 4 points (Table 5). This 
exceeded the MID, estimated as 2 points [26]. After 2 years, the mean score was in line 
with baseline value. Patients experienced statistically significant changes between time 
points in breathlessness (F= 4.729, P=0.022) and energy (F= 4.534, P=0.025). The 
impact level of the CAT showed an increase of patients with a low-medium score (0-20) 
after 1 year, thus experiencing a lower burden of symptoms. 
After 1 year, the utility score calculated from the EQ-5D and the EQ Visual 
Analogue Scale (EQ VAS) increased by 0.036 and 15.7 points, respectively. Both 
measures declined during the second year. A repeated measures ANOVA did not show 
any statistically significant difference between time points for the EQ-5D states, the EQ 
VAS or any of the five dimensions. Overall, patients perceived an improvement of 
symptoms and quality of life during the first year, while during the second year they 
experienced a decline with results in line with those at baseline. 
The average score from the PGIC questionnaire was 5.5±1.2. Nine out of 10 
patients expressed a change-score ≥5 which is considered a significant and favourable 
change of their conditions, including activity, limitations, symptoms, emotions and 
overall quality of life [24]. Only 1 patient reported a little improvement (score 3), but 
without a noticeable change. To note that this patient had an exacerbation while 
attending the 2-year visit. 
Healthcare utilisation 
Overall, healthcare utilisation during the 2 years of follow-up was reduced by 32% 
compared to the 2 years prior to enrolment. In specific, 11 COPD-related 
hospitalisations and 38 COPD-related outpatients visits occurred during the follow-up, 
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while 5 and 67 respectively occurred during the previous period. Only two patients had 
a history of hospitalisation during the previous 2 years. Patients were thus not 
characterized by a high risk for hospitalisation and readmission. Average hospital 
length-of-stay was 4.6 days before the intervention and 5.3 days during the follow-up.  
 
Discussion 
We conducted a pilot study where telerehabilitation was offered to patients with COPD 
for 2 years. This intervention is innovative and brings PR in the patient’s home, thus 
allowing remote supervision at distance. To our knowledge, this is the first 
telerehabilitation intervention with such a long-term follow-up. Ten patients were 
recruited after attending a PR program and participated actively to the intervention, 
maintaining their exercise and self-management routines along the whole study 
duration. No dropout occurred. In other long-term studies in PR dropout rates ranged 
from 21% [27] to 41% [28]. Long-term telerehabilitation is a feasible intervention and 
represents an effective strategy for long-term exercise maintenance and self-
management. 
For people living in rural areas it can be difficult to participate in traditional 
centre-based PR programs. In Norway, PR is offered either as 6 to 8-week outpatient 
program or as 4-week inpatient program. Practical barriers include harsh weather 
conditions, long traveling distances, and lack of follow-up programs locally. Home-
based programmes have the potential to overcome these barriers and improve access to 
PR in underserved areas [16]. Telerehabilitation can also increase access to PR in urban 
areas, where PR programs are limited. Telerehabilitation might represent an innovative 
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and efficient strategy to provide both short-term PR programs and long-term 
maintenance strategies. Any individual could potentially perform PR at home remotely 
supervised by health personnel. 
In the absence of any maintenance strategy, benefits of PR appear to diminish 
after 6-12 months [5,29]. The reasons for this decline include decrease in adherence to 
therapy, especially long-term regular exercise, progression of underlying disease and 
comorbidities, and exacerbations [30]. The telerehabilitation intervention trialled in this 
study aimed to support patients with COPD in maintaining benefits of PR in a long 
term. Results showed that physical performance, lung capacity, health status, and 
quality of life were all maintained at 2 years after completion of PR. Moreover, 6MWD, 
FEV1 and CAT score improved considerably at 1 year compared to baseline. 
Statistically significant improvements were detected at 1 year for breathlessness and 
energy levels, which may explain the increase in lung capacity and functional exercise 
capacity, respectively. Similarly, patients reported a higher quality of life after 1 year. 
Since this study did not have a control group, comparison of outcomes is possible only 
with similar populations from other studies with follow-up longer than 12 months. 
Figure 3 shows the results of the 6MWD for the patients undergoing long-term 
telerehabilitation compared to a control group of patients with moderate to severe 
COPD and similar baseline characteristics followed up for 2 years after PR [6]. While in 
Ries et al. there is an overall decline of 10% over the period, patients participating to 
telerehabilitation experienced only a 4% reduction from baseline. 
To date, there is limited evidence of the use of telerehabilitation in COPD. In a 
recent review, telemedicine interventions were promoted through phone calls, websites 
or mobile phones, often combined with education and/or exercise training [13]. 
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However, no study specifically delivered telerehabilitation. A few studies have shown 
promising results for short-term telerehabilitation in COPD [14-19], but none addressed 
long-term effects. 
Other studies evaluated longer-term benefits of maintenance exercise programs 
for patients with COPD with limited results. A 12-month maintenance program of 
weekly telephone contacts plus monthly supervised reinforcement sessions for patients 
with moderate to severe COPD was only modestly successful in maintaining health 
outcomes after PR [6]. In another study, 6 months of daily rehabilitation followed by 6 
months of weekly supervised maintenance showed improvements in exercise tolerance, 
dyspnoea, and quality of life compared with a control group of subjects with moderate 
to severe COPD, but benefits diminished over the second year of follow-up [27]. 
Weekly maintenance training for 12 months after PR in moderate to severe COPD 
improved walking time but had no influence on quality of life or hospital admissions, 
compared with unsupervised daily training at home [31]. In a 12-month follow-up 
study, both weekly, supervised, outpatient-based exercise plus unsupervised home 
exercise and standard care of unsupervised home exercise successfully maintained 
6MWD and quality of life in subjects with moderate COPD [32]. Participation in 
regular walking after completing PR was associated with slower declines in quality of 
life and walking self-efficacy as well as less progression of dyspnoea for patients with 
moderate to severe COPD [33]. Despite some positive results, no study had succeeded 
in maintaining the benefits of PR for a period longer than 1 year. In our pilot study, all 
outcomes at 2 years were still in line with baseline values. 
The optimal combination of maintenance interventions after completion of a PR 
program remains unknown [3]. Telemedicine may represent a cost-effective alternative 
14 
for the follow-up of patients with COPD. In stable, optimized COPD patients who 
completed PR, telemonitoring reduced primary care chest contacts [34]. We believe that 
long-term telerehabilitation is an innovative intervention which might also limit the use 
of hospital resources. 
Limitations 
This study primarily aimed to investigate the feasibility of telerehabilitation on long-
term exercise maintenance in COPD. Due to the innovative nature of the intervention, 
the study did not have any control group. However, its findings are unique. A 
multicentre randomized controlled trial (RCT) is currently ongoing to test clinical and 
cost-effectiveness of this long-term telerehabilitation. 
Most of the existing studies have focused on attendance to short-term PR 
programs [35], where participants are required to undertake at least 70% of planned 
sessions [36]. The challenges of long-term adherence to exercise in COPD are not 
addressed [37]. In absence of reliable published data, and due to the 2-year follow-up 
during which interruptions were expected, we did not have any a priori definition of 
completion rate. The average adherence rate for registrations of daily measurements and 
training sessions was 43% and 56%, respectively. These results appear to be in line with 
adherence to long-term therapy in chronic diseases, which averages to 50% [38]. 
Due to the small sample, one physiotherapist was responsible to supervise the 
ten participants during the 2-year period. Another physiotherapist was substitute during 
holiday, absence or sick leave. The high completion rate and exercise maintenance 
might have been influenced by the presence of one motivated physiotherapist. Use of 
telerehabilitation in real settings should take into account variations due to supervision 
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by different physiotherapists. Moreover, the study was conducted with voluntary 
participants willing to attend telerehabilitation. This might also have represented a 
selection bias and influenced positively the results. 
Patients with COPD experience often repeated exacerbations which can lead to a 
worsening of the health condition and to hospital admissions [39]. Most expenditures 
for COPD are for hospitalisations and emergency department visits, which account for 
over 70% of healthcare costs [40]. Long-term telerehabilitation, thanks to the benefits 
maintained over time, has the potential to prevent exacerbations in COPD and limit 
healthcare utilisation, which is expected to increase along with disease progression. A 
systematic cost analysis taking into accounts differential costs and savings was out of 
the scope of this study. Moreover, the participants had a low risk for readmission. 
Equipment costs included NOK 12,000 per patient for the 2-year period for treadmill, 
pulse oximeter, tablet, and holder, plus NOK 2,000 per patient per year for 
videoconferencing. These were covered by project funding. The participants kept the 
equipment after the study end. Assuming a 4-year equipment life expectancy, and 2-
hour monthly follow-up per patient, yearly costs per patient would be approximately 
NOK 5,500 and NOK 6,500 for equipment and physiotherapist’s time, respectively. As 
a mean of comparison, the average cost of a COPD-related hospitalisation and a COPD-
related outpatient visit was NOK 60,000 and NOK 2,000, respectively. We believe that 
telerehabilitation might represent a cost-effective strategy and a valuable supplement to 
PR programs and maintenance programs. This hypothesis has to be tested with a proper 
RCT comparing long-term telerehabilitation to usual care.  
Conclusion 
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Long-term exercise maintenance in COPD via telerehabilitation is feasible and patients 
succeeded in maintaining exercise over 2 years. Deterioration in the disease is expected 
over time [29,30]. Results from this pilot study are encouraging and suggest that 
telerehabilitation can prevent deterioration, improve physical performance, health 
status, quality of life, and limit hospital accesses. 
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Table 1.  Inclusion and exclusion criteria. 
Inclusion criteria Exclusion criteria 
Moderate/severe diagnosis of COPD in 
accordance with the GOLD guidelines [20] 
Unwillingness or inability to give informed consent 
Completion of a rehabilitation programme 
during the previous 6 months 
Presence of comorbidities or physical conditions 
which might interfere with home rehabilitation 
Aged 40-75 years Home environment not suitable for installation and 
use of training and monitoring equipment (e.g. 
space, Internet connection, family needs) 
Resident in Northern Norway 
Norwegian-speaking 
	
Table 2.  Study objectives. 
Objectives Measure 
Feasibility Completion rate 
Exercise maintenance Frequency of training sessions  
Self-management maintenance Frequency of daily registrations 
Physical performance 6MWD 
Lung capacity FEV1 (% of pred.) 
Body weight status BMI 
Health status CAT 
Quality of life EQ-5D 
Subjective impression of overall change   PGIC 
Healthcare utilisation COPD-related hospitalisations and outpatient visits 
Definition of abbreviations: 6MWD = 6-Minute Walking Distance; FEV1 (% of pred.) = Forced 
expiratory volume in 1 second percentage; BMI = Body Mass Index; CAT = COPD Assessment Test; 
EQ-5D = EuroQol 5 Dimensions; PGIC = Patient global impression of change scale. 
 
Table 3.  Patients’ characteristics at baseline.  
Demographics Measure 
Age, years 55.2 ± 6.1 [48-67] 
Sex  
   Males 5 (50%) 
   Females 5 (50%) 
Patients on LTOT 3 (30%) 
Distance from closest hospital, km 99 ± 76 [3-218] 
Travel time to closest hospital, minutes 101 ± 69 [5-198] 
Patients living alone 5 (50%) 
Patients working 2 (20%) 
Higher educational level  
   Secondary school 1 (10%) 
   High school 7 (70%) 
   University / University College 2 (20%) 
Internet use  
   Never 1 (10%) 
   Every month 1 (10%) 
   Every week 5 (50%) 
   Every day 3 (30%) 
Definition of abbreviations: LTOT = Long-Term Oxygen Therapy. 
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Table 4.  Results from the clinical status. 
Outcomes Baseline 1 year 2 years 
6MWD, m 493 ± 106 533 ± 124 473 ± 108 
FEV1, L (% of pred.) 49.1 ± 20.9 54.9 ± 28.8 45.2 ± 20.6 
BMI, kg/m2 27.9 ± 7.3 26.7 ± 5.5 26.4 ± 5.3 
Definition of abbreviations: 6MWD = 6-Minute Walking Distance; FEV1 (% of pred.) = Forced 
expiratory volume in 1 second percentage; BMI = Body Mass Index. 
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Table 5.  Results from the health status and quality of life. 
CAT Baseline 1 year 2 years 
Total Score 21.5 ± 6.3 17.7 ± 5.5 20.3 ± 6.7 
   Cough 2.2 ± 1.0 2.0 ± 0.8 2.2 ± 1.1 
   Mucus 2.8 ± 1.0 2.2 ± 1.1 2.1 ± 1.4 
   Chest tightening 2.4 ± 1.1 2.2 ± 1.2 2.1 ± 1.0 
   Breathlessness 3.6 ± 1.3 3.0 ± 1.1 3.5 ± 1.0 * 
   Daily activities 3.4 ± 1.3 3.0 ± 0.8 3.0 ± 1.2 
   Confidence 1.5 ± 1.2 1.5 ± 1.3 1.8 ± 1.4 
   Sleep 2.6 ± 1.5 1.7 ± 1.6 2.8 ± 2.0 
   Energy 3.0 ± 1.2 2.1 ± 1.1 2.8 ± 0.9  * 
Impact level    
   Low (CAT <10) 1 (10%) 1 (10%) 0 (0%) 
   Medium (CAT 10-20) 3 (30%) 5 (50%) 4 (40%) 
   High (CAT 21-30) 6 (60%) 4 (40%) 6 (60%) 
   Very high (CAT 31-40) 0 (0%) 0 (0%) 0 (0%) 
EQ-5D Baseline 1 year 2 years 
Utility score 0.624 ± 0.218 0.660 ± 0.210 0.557 ± 0.211 
   Mobility 1.6 ± 0.5 1.5 ± 0.5 1.6 ± 0.5 
   Personal care 1.3 ± 0.5 1.1 ± 0.3 1.1 ± 0.3 
   Usual activities 1.8 ± 0.6 1.9 ± 0.6 2.0 ± 0.7 
   Pain/discomfort 1.7 ± 0.7 1.7 ± 0.7 1.9 ± 0.6 
   Anxiety/depression 1.6 ± 0.5 1.5 ± 0.5 1.7 ± 0.7 
VAS 48.6 ± 21.9 64.2 ± 20.4 52.3 ± 23.9 
Definition of abbreviations: CAT = COPD Assessment Test; EQ-5D = EuroQol 5 Dimensions; VAS = 




Figure 1. Home telemedicine unit, including treadmill, pulse oximeter, iPad and holder. 
 
 




Figure 3. 6MWD for patients undertaking telerehabilitation compared with a control population from 
Ries et al. [6]. 
 
 
